Mepolizumab as a steroid-sparing agent for eosinophilic granulomatosis with poliangiitis: a case series
S. Yamawaki (Tokyo, Japan), R. Tsuzuki (Tokyo, Japan), S. Soeda (Tokyo, Japan), O. Katsube (Tokyo, Japan), Y. Kono (Tokyo, Japan), M. To (Tokyo, Japan), Y. To (Tokyo, Japan)
Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts
Session: Asthma: outcomes of clinical trials and cohorts
Session type: Thematic Poster
Number: 4253
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Yamawaki (Tokyo, Japan), R. Tsuzuki (Tokyo, Japan), S. Soeda (Tokyo, Japan), O. Katsube (Tokyo, Japan), Y. Kono (Tokyo, Japan), M. To (Tokyo, Japan), Y. To (Tokyo, Japan). Mepolizumab as a steroid-sparing agent for eosinophilic granulomatosis with poliangiitis: a case series. 4253
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: